Index-Nr.
|
Chemische Bezeichnung
|
EG-Nr.
|
CAS-Nr.
|
Einstufung
|
Kennzeichnung
|
Spezifische Konzentrationsgrenzen, M-Faktoren und ATE
|
Anmerkungen
|
Gefahrenklasse, Gefahrenkategorie und Gefahrenkodierung
|
Kodierung der Gefahrenhinweise
|
Piktogramm, Kodierung der Signalworte
|
Kodierung der Gefahrenhinweise
|
Kodierung der ergänzenden Gefahrenmerkmale
|
„005-007-00-2
|
Borsäure [1]
Borsäure [2]
|
233-139-2 [1]
234-343-4 [2]
|
10043-35-3 [1]
11113-50-1 [2]
|
Repr. 1B
|
H360FD
|
GHS08
Dgr
|
H360FD“
|
|
|
|
„005-008-00-8
|
Dibortrioxid
|
215-125-8
|
1303-86-2
|
Repr. 1B
|
H360FD
|
GHS08
Dgr
|
H360FD“
|
|
|
|
„005-011-00-4
|
Tetrabordinatriumheptaoxid, Hydrat; [1]
Dinatriumtetraborat, wasserfrei; [2]
Orthoborsäure, Natriumsalz [3]
Dinatriumtetraboratdecahydrat [4]
Dinatriumtetraboratpentahydrat [5]
|
235-541-3 [1]
215-540-4 [2]
237-560-2 [3]
215-540-4 [4]
215-540-4 [5]
|
12267-73-1 [1]
1330-43-4 [2]
13840-56-7 [3]
1303-96-4 [4]
12179-04-3 [5]
|
Repr. 1B
|
H360FD
|
GHS08
Dgr
|
H360FD“
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
„006-069-00-3
|
Thiophanat-methyl (ISO);
Dimethyl-(1,2-phenylendicarbamothioyl)biscarbamat;
Dimethyl-4,4’-(o-phenylen)bis(3-thioallophanat)
|
245-740-7
|
23564-05-8
|
Carc. 2
Muta. 2
Acute Tox. 4
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H351
H341
H332
H317
H400
H410
|
GHS08
GHS07
GHS09
Wng
|
H351
H341
H332
H317
H410
|
|
Einatmen: ATE = 1,7 mg/L
(Stäube und Nebel)
M = 10
M = 10“
|
|
„006-076-00-1
|
Mancozeb (ISO); Manganethylen-bis(dithiocarbamat) (polymer), Komplex mit Zinksalz
|
-
|
8018-01-7
|
Carc. 2
Repr. 1B
STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H351
H360D
H373 (Schilddrüse, Nervensystem)
H317
H400
H410
|
GHS08
GHS07
GHS09
Dgr
|
H351
H360D
H373 (Schilddrüse, Nervensystem)
H317
H410
|
|
M = 10
M = 10“
|
|
„015-113-00-0
|
Tolclofos-methyl (ISO);
O-(2,6-Dichlor-p-tolyl) O,O-dimethylthiophosphat
|
260-515-3
|
57018-04-9
|
Skin Sens. 1B
Aquatic Acute 1
Aquatic Chronic 1
|
H317
H400
H410
|
GHS07
GHS09
Wng
|
H317
H410
|
|
M = 1
M = 1“
|
|
„028-007-00-4
|
Trinickeldisulfid;
Nickelsubsulfid; [1]
Heazlewoodit [2]
|
234-829-6 [1]
- [2]
|
12035-72-2 [1]
12035-71-1 [2]
|
Carc. 1A
Muta. 2
Acute Tox. 3
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H350i
H341
H331
H372**
H317
H400
H410
|
GHS08
GHS06
GHS09
Dgr
|
H350i
H341
H331
H372**
H317
H410
|
|
Einatmen:
ATE = 0,92 mg/L
(Stäube oder Nebel)“
|
|
„029-002-00-X
|
Dikupferoxid;
Kupfer(I)-oxid
|
215-270-7
|
1317-39-1
|
Acute Tox. 4
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H302
H318
H400
H410
|
GHS07
GHS05
GHS09
Dgr
|
H332
H302
H318
H410
|
|
Einatmen: ATE = 3,34 mg/L (Stäube oder Nebel)
oral: ATE = 500 mg/kg KG
M = 100
M = 10“
|
|
„029-015-00-0
|
Kupferthiocyanat
|
214-183-1
|
1111-67-7
|
Aquatic Acute 1
Aquatic Chronic 1
|
H400
H410
|
GHS09
Wng
|
H410
|
EUH032
|
M = 10
M = 10“
|
|
„029-016-00-6
|
Kupfer(II)-oxid
|
215-269-1
|
1317-38-0
|
Aquatic Acute 1
Aquatic Chronic 1
|
H400
H410
|
GHS09
Wng
|
H410
|
|
M = 100
M = 10“
|
|
„029-017-00-1
|
Dikupferchloridtrihydroxid
|
215-572-9
|
1332-65-6
|
Acute Tox. 4
Acute Tox. 3
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H301
H400
H410
|
GHS06
GHS09
Dgr
|
H332
H301
H410
|
|
Einatmen: ATE = 2,83 mg/L (Stäube oder Nebel)
oral: ATE = 299 mg/kg KG
M = 10
M = 10“
|
|
„029-018-00-7
|
Tetrakupferhexahydroxidsulfat; [1]
Tetrakupferhexahydroxidsulfathydrat [2]
|
215-582-3 [1]
215-582-3 [2]
|
1333-22-8 [1]
12527-76-3 [2]
|
Acute Tox. 4
Aquatic Acute 1
Aquatic Chronic 1
|
H302
H400
H410
|
GHS07
GHS09
Wng
|
H302
H410
|
|
oral: ATE = 500 mg/kg KG
M = 10
M = 10“
|
|
„029-019-01-X
|
Kupferflocken (mit einem Überzug aus aliphatischer Säure)
|
-
|
-
|
Acute Tox. 3
Acute Tox. 4
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H331
H302
H319
H400
H410
|
GHS06
GHS09
Dgr
|
H331
H302
H319
H410
|
|
Einatmen: ATE = 0,733 mg/L (Stäube oder Nebel)
oral: ATE = 500 mg/kg KG
M = 10
M = 10“
|
|
„029-020-00-8
|
Kupfer(II)-carbonat — Kupfer(II)-hydroxid (1:1)
|
235-113-6
|
12069-69-1
|
Acute Tox. 4
Acute Tox. 4
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H302
H319
H400
H410
|
GHS07
GHS09
Wng
|
H332
H302
H319
H410
|
|
Einatmen: ATE = 1,2 mg/L (Stäube oder Nebel)
oral: ATE = 500 mg/kg KG
M = 10
M = 10“
|
|
„029-021-00-3
|
Kupferdihydroxid;
Kupfer(II)-hydroxid
|
243-815-9
|
20427-59-2
|
Acute Tox. 2
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H330
H302
H318
H400
H410
|
GHS06
GHS05
GHS09
Dgr
|
H330
H302
H318
H410
|
|
Einatmen: ATE = 0,47 mg/L (Stäube oder Nebel)
oral: ATE = 500 mg/kg KG
M = 10
M = 10“
|
|
„029-022-00-9
|
Bordeauxbrühe;
Reaktionsprodukte von Kupfersulfat mit Calciumdihydroxid
|
-
|
8011-63-0
|
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H318
H400
H410
|
GHS07
GHS05
GHS09
Dgr
|
H332
H318
H410
|
|
Einatmen: ATE = 1,97 mg/L (Stäube oder Nebel)
M = 10
M = 1“
|
|
„029-023-00-4
|
Kupfersulfat-Pentahydrat
|
231-847-6
|
7758-99-8
|
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H302
H318
H400
H410
|
GHS07
GHS05
GHS09
Dgr
|
H302
H318
H410
|
|
oral: ATE = 481 mg/kg KG
M = 10
M = 1“
|
|
„601-029-00-7
|
Dipenten;
Limonen [1]
(S)-p-Mentha-1,8-dien; l-Limonen [2]
trans-1-Methyl-4-(1-methylvinyl)cyclohexen; [3]
(±)-1-Methyl-4-(1-methylvinyl)-cyclohexen [4]
|
205-341-0 [1]
227-815-6 [2]
229-977-3 [3]
231-732-0 [4]
|
138-86-3 [1]
5989-54-8 [2]
6876-12-6 [3]
7705-14-8 [4]
|
Flam. Liq. 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H226
H315
H317
H400
H410
|
GHS02
GHS07
GHS09
Wng
|
H226
H315
H317
H410
|
|
|
C“
|
„601-096-00-2
|
(R)-p-Mentha-1,8-dien;
d-Limonen
|
227-813-5
|
5989-27-5
|
Flam. Liq. 3
Skin Irrit. 2
Skin Sens. 1B
Asp. Tox. 1
Aquatic Acute 1
Aquatic Chronic 3
|
H226
H315
H317
H304
H400
H412
|
GHS02
GHS07
GHS08
GHS09
Dgr
|
H226
H315
H317
H304
H410
|
|
M = 1“
|
|
„603-024-00-5
|
1,4-Dioxan
|
204-661-8
|
123-91-1
|
Flam. Liq. 2
Carc. 1B
STOT SE 3
Eye Irrit. 2
|
H225
H350
H335
H319
|
GHS02
GHS08
GHS07
Dgr
|
H225
H350
H335
H319
|
EUH019
EUH066
|
|
D“
|
„603-066-00-4
|
7-Oxa-3-oxiranylbicyclo[4.1.0]heptan; 1,2-Epoxy-4-epoxyethylcyclohexan; 4-Vinylcyclohexendiepoxid
|
203-437-7
|
106-87-6
|
Carc. 1B
Muta. 2
Repr. 1B
Acute Tox. 3
Acute Tox. 4
|
H350
H341
H360F
H331
H302
|
GHS08
GHS06
Dgr
|
H350
H341
H360F
H331
H302
|
|
Einatmen: ATE = 0,5 mg/L (Stäube oder Nebel)
oral: ATE = 1 847 mg/kg KG“
|
|
„603-098-00-9
|
2-Phenoxyethanol
|
204-589-7
|
122-99-6
|
Acute Tox. 4
STOT SE 3
Eye Dam. 1
|
H302
H335
H318
|
GHS05
GHS07
Dgr
|
H302
H335
H318
|
|
oral:
ATE = 1 394 mg/kg KG“
|
|
„606-004-00-4
|
4-Methylpentan-2-on; Isobutylmethylketon
|
203-550-1
|
108-10-1
|
Flam. Liq. 2
Carc. 2
Acute Tox. 4
STOT SE 3
Eye Irrit. 2
|
H225
H351
H332
H336
H319
|
GHS02
GHS07
GHS08
Dgr
|
H225
H351
H332
H336
H319
|
EUH066
|
Einatmen: ATE = 11 mg/L (Dämpfe)“
|
|
„607-421-00-4
|
Cypermethrin (ISO);
α-Cyan-3-phenoxybenzyl 3-(2,2-dichlorvinyl)-2,2-dimethylcyclopropancarboxylat; Cypermethrin cis/trans +/-40/60
|
257-842-9
|
52315-07-8
|
Acute Tox. 4
Acute Tox. 4
STOT SE 3
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H302
H335
H373 (Nervensystem)
H400
H410
|
GHS07
GHS08
GHS09
Wng
|
H332
H302
H335
H373 (Nervensystem)
H410
|
|
oral: ATE = 500 mg/kg KG
Einatmen: ATE = 3,3 mg/L (Stäube oder Nebel)
M = 100000
M = 100000“
|
|
„607-424-00-0
|
Trifloxystrobin (ISO); Methyl(E)-methoxyimino-{(E)-α-[1-(α,α,α-trifluor-m-tolyl)ethylidenaminooxy]-o-tolyl}acetat
|
-
|
141517-21-7
|
Lact.
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H362
H317
H400
H410
|
GHS07
GHS09
Wng
|
H362
H317
H410
|
|
M = 100
M = 10“
|
|
„607-434-00-5
|
Mecoprop-P (ISO) [1] und seine Salze;
(R)-2-(4-Chlor-2-methylphenoxy)propionsäure [1] und ihre Salze
|
240-539-0 [1]
|
16484-77-8 [1]
|
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H302
H318
H400
H410
|
GHS07
GHS05
GHS09
Dgr
|
H302
H318
H410
|
|
oral: ATE = 431 mg/kg KG
M = 10
M = 10“
|
|
„608-058-00-4
|
Esfenvalerat (ISO);
(S)-α-Cyan-3-phenoxybenzyl-(S)-2-(4-chlorphenyl)-3-methylbutyrat
|
-
|
66230-04-4
|
Acute Tox. 3
Acute Tox. 3
STOT SE 1
STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H331
H301
H370 (Nervensystem)
H373
H317
H400
H410
|
GHS06
GHS08
GHS09
Dgr
|
H331
H301
H370 (Nervensystem)
H373
H317
H410
|
|
oral; ATE = 88,5 mg/kg KG
Einatmen: ATE = 0,53 mg/L (Stäube oder Nebel)
M = 10 000
M = 10 000 “
|
|
„612-067-00-9
|
3-Aminomethyl-3,5,5-trimethylcyclohexylamin
|
220-666-8
|
2855-13-2
|
Acute Tox. 4
Skin Corr. 1B
Eye Dam. 1
Skin Sens. 1A
|
H302
H314
H318
H317
|
GHS05
GHS07
Dgr
|
H302
H314
H317
|
|
oral: ATE = 1 030 mg/kg KG
Skin Sens. 1A; H317: C ≥ 0,001 %“
|
|
„612-252-00-4
|
Imidacloprid (ISO);
(E)-1-(6-Chlor-3-pyridylmethyl)-N-nitroimidazolidin-2-ylideneamin;
(2E)-1-[(6-Chlorpyridin-3-yl) methyl]-N-nitroimidazolidin-2-imin
|
428-040-8
|
138261-41-3
|
Acute Tox. 3
Aquatic Acute 1
Aquatic Chronic 1
|
H301
H400
H410
|
GHS06
GHS09
Dgr
|
H301
H410
|
|
oral: ATE = 131 mg/kg KG
M = 100
M = 1 000 “
|
|
„613-048-00-8
|
Carbendazim (ISO); Methylbenzimidazol-2-ylcarbamat
|
234-232-0
|
10605-21-7
|
Muta. 1B
Repr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H340
H360FD
H317
H400
H410
|
GHS07
GHS08
GHS09
Dgr
|
H340
H360FD
H317
H410
|
|
M = 10
M = 10“
|
|
„613-102-00-0
|
Dimethomorph (ISO); (E,Z)-4-(3-(4-Chlorphenyl)-3-(3,4-dimethoxyphenyl)acryloyl)morpholin
|
404-200-2
|
110488-70-5
|
Repr. 1B
Aquatic Chronic 2
|
H360F
H411
|
GHS08
GHS09
Dgr
|
H360F
H411“
|
|
|
|
„613-111-00-X
|
1,2,4-Triazol
|
206-022-9
|
288-88-0
|
Repr. 1B
Acute Tox. 4
Eye Irrit. 2
|
H360FD
H302
H319
|
GHS08
GHS07
Dgr
|
H360FD
H302
H319
|
|
oral: ATE = 1 320 mg/kg KG“
|
|
„613-166-00-X
|
Flumioxazin (ISO);
N-(7-Fluor-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H-1,4-benzoxazin-6-yl)cyclohex-1-en-1,2-dicarboximid
|
-
|
103361-09-7
|
Repr. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H361d
H400
H410
|
GHS08
GHS09
Wng
|
H361d
H410
|
|
M = 1 000
M = 1 000 “
|
|
„613-208-00-7
|
Imazamox (ISO);
(RS)-2-(4-Isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinsäure
|
-
|
114311-32-9
|
Repr. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H361d
H400
H410
|
GHS08
GHS09
Wng
|
H361d
H410
|
|
M = 10
M = 10“
|
|
„613-267-00-9
|
Thiamethoxam (ISO);
3-(2-Chlor-thiazol-5-ylmethyl)-5-methyl[1,3,5]oxadiazinan-4-yliden-N-nitroamin
|
428-650-4
|
153719-23-4
|
Repr. 2
Acute Tox. 4
Aquatic Acute 1
Aquatic Chronic 1
|
H361fd
H302
H400
H410
|
GHS07
GHS08
GHS09
Wng
|
H361fd
H302
H410
|
|
oral: ATE = 780 mg/kg KG
M = 10
M = 10“
|
|
„613-282-00-0
|
Triticonazol (ISO);
(RS)-(E)-5-(4-Chlorbenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol
|
-
|
138182-18-0
|
Repr. 2
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
|
H361f
H373
H400
H410
|
GHS08
GHS09
Wng
|
H361f
H373
H410
|
|
M = 1
M = 1“
|
|
„616-032-00-9
|
Diflufenican (ISO);
N-(2,4-Difluorphenyl)-2-[3-(trifluormethyl)phenoxy]-3-pyridincarboxamid; 2′,4′-Difluor-2-(α,α,α-trifluor-m-tolyloxy)nicotinanilid
|
-
|
83164-33-4
|
Aquatic Acute 1
Aquatic Chronic 1
|
H400
H410
|
GHS09
Wng
|
H410
|
|
M = 10 000
M = 1 000 “
|
|
„616-106-00-0
|
Phenmedipham (ISO); Methyl-3-(3-methylcarbaniloyloxy)carbanilat
|
237-199-0
|
13684-63-4
|
Aquatic Acute 1
Aquatic Chronic 1
|
H400
H410
|
GHS09
Wng
|
H410
|
|
M = 10
M = 10“
|
|
„616-113-00-9
|
Desmedipham (ISO);
Ethyl-3-phenylcarbamoyloxyphenylcarbamat
|
237-198-5
|
13684-56-5
|
Repr. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H361d
H400
H410
|
GHS08
GHS09
Wng
|
H361d
H410
|
|
M = 10
M = 10“
|
|